This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue 4 , Page e114-e118, April 1, 2025. Intracranial atherosclerotic stenosis is a leading cause of stroke with a significant risk of recurrent ischemic events despite aggressive medical management. However, 3 percutaneous angioplasty and stenting randomized trials showed negative or neutral results.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Herein, we describe a single‐step approach to deploy Neuroform Atlas stent (Stryker Neurovascular, Fremont, CA) which is a hybrid laser‐cut, nitinol self‐expanding stent without the need for ELW or lesion re‐access using MINI TREK RX (Abbott Vascular, Inc.,
Stroke, Volume 55, Issue Suppl_1 , Page AWMP88-AWMP88, February 1, 2024. Background:In stroke patients undergoing EVT, angioplasty and stenting (A&S) has been described as a bailout technique when thrombectomy fails or intracranial stenosis is suspected. Further prospective data is warranted.
Stroke, Volume 56, Issue Suppl_1 , Page ATP248-ATP248, February 1, 2025. Objective:Silent brain infarctions (SBIs), which appear as dot-like lesions on diffusion-weighted imaging (DWI) after endovascular procedures, are associated with an increased risk of subsequent stroke, dementia and cognitive decline.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionVertebral artery stenting represents a viable option in treating symptomatic vertebral artery atherosclerotic stenosis. Those reporting patients with vertebral dissections were excluded.
Interestingly, while rates of all-cause mortality did not differ significantly between PCI and CABG groups, PCI was associated with lower early stroke rates. Pooled data from four trials were analyzed, encompassing patients undergoing PCI or CABG for left main disease.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerotic disease (ICAD) is associated with up to 32% of posterior circulation strokes.1 1 ICAD‐related strokes are at high risk for re‐occlusion following MT.
Stroke, Volume 55, Issue Suppl_1 , Page AWP179-AWP179, February 1, 2024. Background:Stent-retriever thrombectomy is the first-line therapy for acute stroke with intracranial large vessel occlusion. In cases of stent-retriever thrombectomy failure, rescue stentangioplasty might be the sole option for achieving permanent recanalization.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP94-AWMP94, February 1, 2025. Introduction:Medical therapy and endovascular therapy for intracranial atherosclerotic disease (ICAD) have evolved over the past two decades with improved medical therapy benchmarks, and improved techniques and patient selection for stenting.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerosis (ICAS) is a leading global cause of stroke. The role of intracranial stenting in ICAS remains uncertain. 1‐year rate of stroke and death in stented patients [5].
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThe optimal management strategy for large vessel occlusion strokes (LVOS) from intracranial atherosclerotic disease (ICAD) remains debated. Endovascular intervention was defined as either angioplasty, stenting, or a combination of both.
Stroke, Volume 56, Issue Suppl_1 , Page ADP36-ADP36, February 1, 2025. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. Additional randomized and controlled clinical research is deserved.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Recent research has identified venous sinus stenosis as a cause of IIH, a common treatment of which is venous stenting and angioplasty. The patient had an Onyx Resolute stent placed in the right transverse sigmoid junction.
Stroke, Volume 55, Issue Suppl_1 , Page ATP191-ATP191, February 1, 2024. Introduction:For a subset of patients with acute ischemic stroke (AIS) with large vessel occlusion (LVO) mechanical thrombectomy with a stent retriever and/or aspiration is insufficient to revascularize the target artery.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionMechanical thrombectomy (MT) often fails to achieve successful reperfusion in up to 20% of acute ischemic stroke (AIS) patients with large vessel occlusion (LVO) [1, 2].
Stroke, Volume 55, Issue Suppl_1 , Page ATMP94-ATMP94, February 1, 2024. Introduction:Current evidence suggests that acute carotid artery stenting (CAS) for cervical lesions is associated with better functional outcomes in patients with acute stroke with tandem lesions (TLs) treated with endovascular treatment (EVT).
Rates of stroke within 1 year were lower with PCI versus CABG in the entire population, with no heterogeneity based on diabetes status (PintHR=0.51). Rates of all-cause mortality did not differ after PCI versus CABG in those with (84/563 [15.3%] versus 74/541 [14.1%]; hazard ratio, 1.11 [95% CI, 0.82–1.52]) PintHR=0.87) diabetes.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP58-ATMP58, February 1, 2025. Baseline demographics and National Institutes of Health Stroke Scale (NIHSS) were similar between groups. However, in hyperacute ischemic infarcts, diffusion-weighted imaging (DWI) hyperintense lesions can show varying ADC values. P < 0.0001). ml/h vs. 7.5
Stroke, Ahead of Print. Asymptomatic high-grade carotid stenosis is an important therapeutic target for stroke prevention. Since then, transfemoral/transradial carotid stenting and transcarotid artery revascularization have emerged as alternatives to endarterectomy for revascularization.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Patients who received thrombolysis and subsequently underwent endovascular therapy for acute ischemic stroke between 2012 and 2022 were included. IntroductionThe risk of tandem occlusion treatment in the setting of intravenous thrombolysis is unclear.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. Patients with poorly controlled diabetes also were more likely to require angioplasty (31.3% or greater. or greater.
Stroke, Volume 55, Issue Suppl_1 , Page A158-A158, February 1, 2024. The patients were divided into two groups: those who received RS (including balloon angioplasty alone, intracranial stenting with or without balloon angioplasty) and those who only received MM. MM: 9%, aOR=0.32, 95%CI 0.14-0.71,p=0.005) p=<0.001).Conclusion:Our
Stroke, Volume 56, Issue Suppl_1 , Page AWP286-AWP286, February 1, 2025. Background:Hemodynamic evaluation is crucial in assessing stroke risk in patients with symptomatic intracranial atherosclerotic stenosis (sICAS). Twenty patients (9.6%) experienced ischemic stroke or TIA during the one-year follow-up. before PTAS.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionVertebral artery web has been rarely identified compared to the frequently reported, carotid artery web as etiology of ischemic stroke. Vertebral artery web has limited scientific documentation throughout the literature. Lenck et al.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP9-AWMP9, February 1, 2024. Introduction:Intracranial atherosclerotic disease (ICAD) is a common cause of ischemic stroke worldwide. In the ICADLVO group, 23 out of 68 patients underwent angioplasty, whereas 38 patients received stenting.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerosis‐related large vessel occlusion (ICAS‐LVO) is a common cause of failed mechanical thrombectomy (MT) in acute ischemic stroke (AIS) [1].
Stroke: Vascular and Interventional Neurology, Ahead of Print. Most respondents (86%) preferred acute treatment of ICAS‐LVO with rescue stenting (RS)±angioplasty. Fear of hemorrhagic complications (74%) was the most compelling reason not to perform RS±angioplasty.
Stroke, Volume 56, Issue Suppl_1 , Page ATP247-ATP247, February 1, 2025. Of the 32 patients, 9(28.1%) had dissection with diagnostic angiograms, 6(18.8%) endovascular thrombectomy, 15(46.9%) aneurysm treatment, and 2(6.3%) angioplasty with or without stenting. Only 4(12.5%) were treated with hyperacute stenting.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP10-ATMP10, February 1, 2025. Introduction:An optimal strategy for the treatment of intracranial atherosclerotic disease (ICAD) has remained unclear, despite medical therapy (antiplatelet therapy and LDL control management) or endovascular therapy (angioplasty or stenting).
Stroke, Volume 56, Issue Suppl_1 , Page AWP252-AWP252, February 1, 2025. Introduction:Underlying Intracranial atherosclerotic disease (ICAD) may influence mechanical thrombectomy recanalization, leading to an increased number of passes before rescue techniques are adopted.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionFlow diverters (FD) are stent‐type devices that enable the exclusion of intracranial aneurysms in clinical scenarios where coil‐type devices exhibit high failure rates. years (±13.3). Neck measurements were in the range of 1.9
Stroke, Volume 55, Issue Suppl_1 , Page AWMP87-AWMP87, February 1, 2024. Balloon angioplasty was the treatment technique in 35% and 1.1%, and intracranial stents in 6.4% and 0%, recurrent stroke 6.4% and 4.2%, while good outcome was similar between 40% and 38%. and 0.05%, respectively. Reocclusion was 3.1%
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerotic disease (ICAD) induces the luminal narrowing of an intracranial vessel and represents one of the major causes of ischemic strokes [1, 2, 3, 4].
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionBasilar artery occlusion (BAO) is a devastating minority stroke subtype with variable clinical presentations and high mortality.1,2 He was treated with aspirin 324mg and transferred to our tertiary stroke center.
Recently there has been a concerning rise in heart attacks and strokes among young adults, often due to unhealthy lifestyle choices such as poor diet, lack of exercise and excessive stress. Procedures such as angioplasty, stenting and bypass surgery can restore blood flow to the heart and improve function.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Options include initial angioplasty and/or stenting of the cervical lesion followed by intracranial thrombectomy versus Dotter navigation of catheters through the cervical lesion to first target the intracranial LVO.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionEmerging evidence suggests a robust association between cardiovascular disease (CVD) and cognitive decline, accentuating the necessity for early detection and intervention. males) and 40 individuals (mean age 55.9 ± 11.9
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerotic disease (ICAD) is one of the most prevalent causes of stroke across the world, with a high morbidity and mortality rate. The primary endpoint was composite of 1‐year stroke, ICH, and/or death.
Once the patient reaches the hospital, the doctors will attempt to remove the clot using either a potent clot buster medicine [thrombolytic medicines] or a surgery known as primary angioplasty. Although both techniques have advantages and limitations, primary angioplasty is the chosen therapy in most cases. Do not smoke.
Stroke, Volume 56, Issue Suppl_1 , Page AWP250-AWP250, February 1, 2025. Distal/medium vessel occlusion (DMVO), coagulopathy, angioplasty or stenting, concurrent intraparenchymal hemorrhage (IPH), and female sex were associated with higher odds of SAH. vs. 10.6%, adjusted OR 2.53 [95%CI 2.23-2.87], vs. 28.0%, aOR 0.58 [95%CI 0.52-0.65],
This can lead to a transient ischemic attack (TIA) or stroke. Carotid Ultrasound : Evaluates blood flow to the brain and detects stroke risk factors. Angioplasty & Stenting: Opens blocked arteries to improve blood flow. Total loss of circulation can lead to gangrene and loss of a limb.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content